491 related articles for article (PubMed ID: 11912113)
1. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Caparros-Lefebvre D; Sergeant N; Lees A; Camuzat A; Daniel S; Lannuzel A; Brice A; Tolosa E; Delacourte A; Duyckaerts C
Brain; 2002 Apr; 125(Pt 4):801-11. PubMed ID: 11912113
[TBL] [Abstract][Full Text] [Related]
2. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
3. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.
Steele JC; Caparros-Lefebvre D; Lees AJ; Sacks OW
Parkinsonism Relat Disord; 2002 Oct; 9(1):39-54. PubMed ID: 12217621
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
[TBL] [Abstract][Full Text] [Related]
5. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.
Caparros-Lefebvre D; Elbaz A
Lancet; 1999 Jul; 354(9175):281-6. PubMed ID: 10440304
[TBL] [Abstract][Full Text] [Related]
6. REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy.
De Cock VC; Lannuzel A; Verhaeghe S; Roze E; Ruberg M; Derenne JP; Willer JC; Vidailhet M; Arnulf I
Sleep; 2007 Aug; 30(8):1026-32. PubMed ID: 17702273
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
[TBL] [Abstract][Full Text] [Related]
8. Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis.
Caparros-Lefebvre D; Lees AJ
Mov Disord; 2005 Aug; 20 Suppl 12():S114-8. PubMed ID: 16092100
[TBL] [Abstract][Full Text] [Related]
9. The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism.
Camuzat A; Romana M; Dürr A; Feingold J; Brice A; Ruberg M; Lannuzel A
Mov Disord; 2008 Dec; 23(16):2384-91. PubMed ID: 18785640
[TBL] [Abstract][Full Text] [Related]
10. Progressive supranuclear palsy--parkinsonian disorder with tau pathology.
Kowalska A; Jamrozik Z; Kwieciński H
Folia Neuropathol; 2004; 42(2):119-23. PubMed ID: 15266787
[TBL] [Abstract][Full Text] [Related]
11. [Progressive supranuclear palsy; an unusual form of parkinsonism].
Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
[TBL] [Abstract][Full Text] [Related]
12. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H
Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589
[TBL] [Abstract][Full Text] [Related]
14. Familial aggregation of parkinsonism in progressive supranuclear palsy.
Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
[TBL] [Abstract][Full Text] [Related]
15. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
[TBL] [Abstract][Full Text] [Related]
16. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
[TBL] [Abstract][Full Text] [Related]
18. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
19. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
Vanacore N; Bonifati V; Colosimo C; Fabbrini G; De Michele G; Marconi R; Nicholl D; Locuratolo N; Romano S; Talarico G; Stocchi F; Bonuccelli U; Lamberti P; Vieregge P; Meco G;
Neurol Sci; 2001 Feb; 22(1):101-3. PubMed ID: 11487180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
